India

HealthTech India 2026

As part of the HealthTech India 2026 cohort, supported by Switzerland’s innovation agency Innosuisse and managed by Swissnex, five Swiss companies specialising in medtech, biotech and lifesciences will be visiting India to explore potential collaborations within India’s health and life sciences ecosystem.

The startups will attend BioAsia 2026 in Hyderabad on February 17 and 18 to participate in networking sessions and meet industry stakeholders. They will be in Bengaluru and other Indian cities during the rest of the week and will engage with Indian startups, corporates and research institutions to explore opportunities to collaborate and co-innovate.

Growing healthcare challenges in India opens up opportunities, and the technologies offered by these startups have the potential to transform the healthcare sector and address gaps in preventive care, regenerative medicine and advanced therapeutics.

Read about the startups participating in HealthTech India 2026 below.

HealthTech India 2026 Startups

    Aseptuva

    Aseptuva is working to prevent infections that patients can catch in hospitals. It has developed a way to disinfect medical catheters using UV-C light, killing germs on and around them. Since catheters are a common source of serious infections, this technology could help reduce hospital stays, ease pressure on healthcare staff and save lives.
    (Medtech)

    Baxiva

    Baxiva is working on new vaccines to fight bacterial infections. Its main focus is on infections caused by E. coli, a major source of antibiotic-resistant disease worldwide, including urinary tract and serious invasive infections. Using its own vaccine technology, Baxiva aims to protect against multiple strains at once and help reduce the spread of antibiotic-resistant infections.
    (Lifesciences)

    Bewe

    Bewe uses a neuroscience-backed mobile game to reduce cravings and consumption of unhealthy foods and improve long-term health. The gamified experience helps rewire automatic responses, leading to sustained behavioural change without strict diets or willpower struggles.
    (Medtech)

    Cellx Biosolutions

    Cellx Biosolutions helps chemical and pharma industries treat chemical waste sustainably. It uses patented microfluidic and robotic technologies to identify and deploy bacteria that break down pollutants such as microplastics, PFAS (per- and polyfluoroalkyl substances which are a large group of man-made chemicals used in products like non-stick cookware, waterproof clothing, food packaging and are often called “forever chemicals” because they don’t break down easily in the environment or the human body), pesticides and pharmaceutical residues in a cost-efficient and environmentally friendly way.
    (Biotech)

    Precise Health

    Precise Health is tackling antimicrobial resistance (AMR) with an AI-driven phage therapy platform. Its products, PhageMatch™ and PhageTailor™, allow clinicians to rapidly identify or engineer the right phage treatment, while building a unique database licensable to pharma.
    (Medtech)
1
5

Partners

Contact

    Atul Kavitake

    Innovation Manager
1
1